OECD appraised NHI and medical reform programs.

Published: 2002-05-14 07:00:00

Updated: 2002-05-14 07:00:00

The OECD evaluated the Korea NHI and current medical reform program and expressed their assessment that the use of expensive drugs after the reform program showed a remarkable increase, causing medical expenditure up while the patient's rights-to-know was substantially improved. The OECD also adv...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK